Who founded Capio Biosciences?

Capio Biosciences was founded by Seungpyo Hong in 2015.

How much funding has Capio Biosciences raised?

Capio Biosciences has disclosed $2.9M raised across 1 round.

Where is Capio Biosciences headquartered?

Capio Biosciences is headquartered in Madison, US.

Capio Biosciences

Madison, US · Founded 2015 · Delaware corporation

Find your way into Capio Biosciences

551 people in our graph share verified history with the Capio Biosciences team — schools, employers, funds. One of them is your warm intro.

Tsendai Chagwederaunlockedknows Andrew Wang · together at Massachusetts Institute of Technology (overlapped)

×2knows the team · via Indiana University Bloomington

×3knows the team · via Massachusetts Institute of Technology

×4knows the team · via Harvard Medical School

knows the team · via University of North Carolina at Chapel Hill

knows the team · via UT Southwestern Medical Center

Capio Biosciences develops the CapioCyte platform, an ultra-sensitive technology for capturing and analyzing circulating tumor cells (CTCs) from whole blood. The oncology diagnostics tool is aimed at cancer research and potential future clinical use to support treatment decisions.

Biotech Healthtech Medical Devices

Founders & leadership

Capio Biosciences was founded in 2015 by Seungpyo Hong.

Seungpyo HonginCofounder and President

Andrew Wang inCo-Founder and Acting CEOPhysician scientist and radiation oncologist at UT Southwestern Medical Center with research focused on applying chemical and biomedical engineering principles to disease treatment. Co-founder and director of Capio Biosciences, which develops the CapioCyte platform for circulating tumor cell analysis.

Board

Susie XuBoard director

Fenlai TanBoard director

David ChenBoard director

Reported raises · per SEC filings

Form D private placements

$2.9M disclosed across 1 round · 2016

▶$2.9MraisedDec 2016 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Susie XuDirector
Andrew WangExecutive Officer, Director
Fenlai TanDirector
Seungpyo HongExecutive Officer, Director
David ChenDirector

Offering amount: $2.9M
Amount sold: $2.9M
First sale: Dec 2016
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

CapyBio3 shared keywordsCapyBio provides tools to measure how closely cells match a target identity and to improve them, helping scientists and biopharma teams reduce failure in drug discovery, build stronger disease models, and advance cell-based therapies. The company applies cell biology and computational methods to cell identity for research, testing, and regenerative medicine.

Companies competing with Capio Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Designing a Better Approach to Monitor Cancer - School of Pharmacypharmacy.wisc.edu · Mar 2024

Frequently asked questions

What does Capio Biosciences do?: Capio Biosciences develops the CapioCyte platform, an ultra-sensitive technology for capturing and analyzing circulating tumor cells (CTCs) from whole blood. The oncology diagnostics tool is aimed at cancer research and potential future clinical use to support treatment decisions.
Who founded Capio Biosciences?: Capio Biosciences was founded by Seungpyo Hong in 2015.
How much funding has Capio Biosciences raised?: Capio Biosciences has disclosed $2.9M raised across 1 round.
Where is Capio Biosciences headquartered?: Capio Biosciences is headquartered in Madison, US.